Matthew Driver
University of New England (Australia)
11 Papers
5 Citations
Matthew Driver is an academic researcher from University of New England (Australia). The author has contributed to research in topics: Medicine & Internal medicine. The author has an hindex of 1, co-authored 1 publications.
Chat about Author
Papers
Apparent Risks of Postural Orthostatic Tachycardia Syndrome Diagnoses After COVID-19 Vaccination and SARS-Cov-2 Infection.
Alan C. Kwan,Joseph E. Ebinger,Janet Wei,Catherine N. Le,Jillian R. Oft,R. Zabner,Debbie Lin Teodorescu,Patrick Botting,Jesse Navarrette,David W. Ouyang,Matthew Driver,Brian Claggett,Brittany Weber,Peng Sheng Chen,Susan Cheng +14 more
TL;DR: Kwan et al. as mentioned in this paper showed that the risk of postural orthostatic tachycardia syndrome (POTS) is increased after COVID-19 vaccination compared to a 90-day control period before exposure.
Cannabis use and anxiety: is stress the missing piece of the puzzle?
TL;DR: With reported self-medication for anxiety being the strongest predictor of frequency of use, it is suggested that researchers, clinicians, and cannabis users pay greater attention to the overlap between stress and anxiety symptomology and the possible misinterpretation of these related but distinct conditions.
Demographic and clinical characteristics associated with variations in antibody response to BNT162b2 COVID-19 vaccination among healthcare workers at an academic medical centre: a longitudinal cohort analysis
Joseph E. Ebinger,Sandy Joung,Yunxian Liu,Min Wu,Brittany Weber,Brian Claggett,Patrick Botting,Nancy Sun,Matthew Driver,Yu-Hung Kao,Briana Khuu,Timothy Wynter,Trevor Trung Nguyen,Mona Alotaibi,John Prostko,Edwin C. Frias,James L. Stewart,Helen S. Goodridge,Peter Chen,Stanley C. Jordan,Mohit P. Jain,Sonia Sharma,Justyna Fert-Bober,Jennifer E. Van Eyk,Margo Minissian,Moshe Arditi,Gil Y. Melmed,Jonathan Braun,Dermot P.B. McGovern,S. Cheng,Kimia Sobhani +30 more
TL;DR: While the IgG-S antibody response remains in the positive range for up to 10 months following initial mRNA vaccination in most adults, determinants of sustained higher antibody levels include prior SARS-CoV-2 infection, female sex, younger age and absence of hypertension.
Variability independent of mean blood pressure as a real-world measure of cardiovascular risk
Joseph E. Ebinger,Matthew Driver,David W. Ouyang,Patrick Botting,Hongwei Ji,Mohamad Rashid,Ciantel A. Blyler,Natalie A. Bello,Florian Rader,Teemu J. Niiranen,Christine M. Albert,Susan Cheng +11 more
TL;DR: In this article , the authors used multivariable Cox proportional hazards regression to examine the association between VIM and both composite and individual outcomes of interest (incident myocardial infarction, heart failure, stroke, and death).
29
Hypertension and Excess Risk for Severe COVID-19 Illness Despite Booster Vaccination
Joseph E. Ebinger,Matthew Driver,Sandy Joung,Teresa Tran,Dení Trejo Barajas,Min Wu,Patrick Botting,Jesse Navarrette,Nancy Sun,S. Cheng +9 more
TL;DR: The findings reveal a persistent and marked association between hypertension and risk for severe COVID-19 illness, even among a fully vaccinated patient population, and indicate persistence and even accentuation of hypertension-related risk in the setting of a more transmissible albeit generally less viru-lent strain of SARS-CoV-2 and in the era of multidose.
15